| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $747.1M | +26.2% |
| Cost of Revenue | $219.9M | +19.3% |
| Gross Profit | $527.3M | +29.4% |
| R&D Expense | $84.6M | +18.4% |
| SG&A Expense | $492.6M | +17.7% |
| Operating Income | -$57.4M | +50.3% |
| Pre-tax Income | -$43.6M | +61.3% |
| Income Tax | $953K | +68.7% |
| Net Income | -$44.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $236.0M | -43.8% |
| Short-term Investments | $347.8M | +199.9% |
| Accounts Receivable | $75.7M | -5.3% |
| Inventory | $21.6M | +54.1% |
| Current Assets | $702.8M | +8.8% |
| Total Assets | $1.02B | +9.5% |
| Current Liabilities | $151.9M | +36.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.9M | +2285.3% |
| Capital Expenditures | $46.3M | +36.5% |
| Investing Cash Flow | -$277.1M | -125.3% |
| Financing Cash Flow | $12.6M | -97.5% |
| Free Cash Flow | $34.5M | +213.0% |
| +60.7% |
| EPS (Basic) | -$1.39 | +61.7% |
| EPS (Diluted) | -$1.39 | +61.7% |
| Total Liabilities |
| $867.3M |
| +3.2% |
| Stockholders' Equity | $152.7M | +68.0% |